Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 676, Issue 1, 2009, Pages 5-10

  Hussain, Ishraq ^a   Rehman, Shakeel ul ^a   Afroze, Dil ^a   Zahoor, Lubna ^a   Abdullah, Safiya ^a   Hafiz, Adil ^a   Shah, Zafar A ^a   Iqbal, Shabir ^a   Shaffi, Mohammad ^a   Das, B C ^b   Siddiqi, Mushtaq A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

Author keywords

Kangri cancer; Mutations; PTEN; Thermally induced cancer; TP53

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXON; FEMALE; GENE FREQUENCY; GENE INSERTION; HUMAN; HUMAN TISSUE; INDIA; KANGRI CANCER; LYMPH NODE; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN CANCER;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CONSERVED SEQUENCE; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; EXONS; FEMALE; GENE FREQUENCY; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; POPULATION GROUPS; PTEN PHOSPHOHYDROLASE; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67349224684     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.02.011     Document Type: Article

References (31)

1. Neve A. Kangri-bum epithelioma in Kashmir. Ind. Med. Gaz. 35 (1900) 81-83
2. Neve E.F. Kangri bum cancer. Br. Med. J. 2 (1923) 1255-1256
3. Neve E.F. Kangri-bum cancer. Ind. Med. Gaz. 76 (1941) 138-140
4. Kaul H.K., and Goyal R.K. A study on Kangri cancer. J. Ind. Med. Prof. 15 (1968) 6643-6646
5. Shera A.H., and Bhan B.M. Clinicopathological behaviour of Kangri cancer. Ind. J. Surg. 48 (1986) 233-238
6. Sanyal B., Shastri S.R., Hakim A., Kharadi M.Y., Tikku J.L., Verma A., Rasool S., and Pathania A.G.S. A clinical profile of skin cancer from Kashmir valley with special reference to "Kangri" cancer. J. Clin. Radiother. Oncol. 4 (1989) 31-36
7. Treves N., and Pack G.T. The development of cancer in bum scars. Surg. Gynecol. Obstet. 51 (1930) 749-782
8. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics. CA Cancer J. Clin. 57 (2007) 43-66
9. Scotto J., Fears T.R., and Fraumeni Jr. J. Incidence of Non-melanoma Skin Cancer in the United States (1983), National Institutes of Health Publication pp. 83-2433
10. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigel C., and Thun M.J. Cancer statistics. CA Cancer J. Clin. 56 (2006) 106-130
11. Brash D.E., Rudolph J.A., Simon J.A., Lin A., McKenna G.J., Baden H.P., Halperin A.J., and Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. 88 (1991) 10124-10128
12. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., and Yamada K.M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280 (1998) 1614-1617
13. Levine A. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
14. Greenblatt M.S., Bennett W.P., Hollstei M., and Harris C.C. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54 (1994) 4855-4878
15. The IARC TP53 mutation database, http://www.iarc.fr/p53/homepage.htm/.
16. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275 (1997) 1943-1947
17. Liaw D., Marsh D.J., Li J., Dahia P.L., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., Eng C., and Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16 (1997) 64-67
18. Guldberg P., Straten P.T., Birck A., Ahrenkiel V., Firkin A.F., and Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57 (1997) 3660-3663
19. Blin N., and Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3 (1976) 2303-2308
20. Orita M., Iwahana H., Kanazawa H., Hayashi K., and Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphism. Proc. Natl. Acad. Sci. 86 (1989) 2766-2770
21. Bassam B.J., Caetano-Anolles G., and Gresshoff P.M. Fast and sensitive silver staining DNA in polyacrylamide gels. Anal. Biochem. 196 (1991) 80-83
22. Bosari S., Marchetti A., Battita F., Graziani D., Borsani G., Loda M., Bevilacque G., and Coggi G. Detection of p53 mutations by single strand conformation polymorphism (SSCP) gel electrophoresis, a comparative study of radioactive and non radioactive silver-stained SSCP analysis. Diagn. Mol. Pathol. 4 (1995) 249-255
23. Popps S., Waltering S., Herbst C., Moll I., and Boukamp P. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int. J. Cancer 99 (2002) 352-360
24. Leffell D.J. The scientific basis of skin cancer. J. Am. Acad. Dermatol. 42 (2000) 18-22
25. Putz A., Hartmann A.A., Fontes P.R.O., Alexandre C.O.P., Silveria D.A., Klug S.J., and Rabes H.M. TP53 mutation pattern of esophageal squamous cell carcinoma in a high risk area (Southern Brazil): role of life style factors. Int. J. Cancer 98 (2002) 99-105
26. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313 (1996) 17-29
27. Bruskov V.I., Malakhova L.V., Masalimov Z.K., and Chernikov A.V. Heat-induced formation of reactive oxygen species and 8-oxoguanine, a biomarker of damage to DNA. Nucleic Acids Res. 30 (2002) 1354-1363
28. Deichmann M., Thome M., Benner A., Egner U., Hartschuh W., and Naher H. PTEN/MMAC1 expression in melanoma resection specimens. Br. J. Cancer 87 (2002) 1431-1436
29. Boni R., Vortmeyer A.O., Burg G., Hofbauer G., and Zhuang Z. The PTEN tumour suppressor gene and malignant melanoma. Melanoma Res. 8 (1998) 300-302
30. Van Gele M., Leonard J.H., Van Roy N., Cook A.L., De Paepe A., and Speleman F. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma. Int. J. Cancer. 92 (2001) 409-413
31. Kubo Y., Urano Y., Hida Y., and Arase S. Lack of somatic mutation in the PTEN gene in squamous cell carcinomas of skin. J. Dermatol. Sci. 19 (1999) 199-201